Potent neutralization by monoclonal human IgM against SARS-CoV-2 is impaired by class switch.
Options
BORIS DOI
Date of Publication
July 5, 2022
Publication Type
Article
Division/Institute
Contributor
Callegari, Ilaria | |
Schneider, Mika | |
Berloffa, Giuliano | |
Mühlethaler, Tobias | |
Holdermann, Sebastian | |
Galli, Edoardo | |
Roloff, Tim | |
Boss, Renate | |
Infanti, Laura | |
Khanna, Nina | |
Egli, Adrian | |
Buser, Andreas | |
Derfuss, Tobias | |
Sanderson, Nicholas S R |
Subject(s)
Series
EMBO reports
ISSN or ISBN (if monograph)
1469-3178
Publisher
EMBO press
Language
English
Publisher DOI
PubMed ID
35548920
Uncontrolled Keywords
Description
To investigate the class-dependent properties of anti-viral IgM antibodies, we use membrane antigen capture activated cell sorting to isolate spike-protein-specific B cells from donors recently infected with SARS-CoV-2, allowing production of recombinant antibodies. We isolate 20, spike-protein-specific antibodies of classes IgM, IgG, and IgA, none of which shows any antigen-independent binding to human cells. Two antibodies of class IgM mediate virus neutralization at picomolar concentrations, but this potency is lost following artificial switch to IgG. Although, as expected, the IgG versions of the antibodies appear to have lower avidity than their IgM parents, this is not sufficient to explain the loss of potency.
File(s)
| File | File Type | Format | Size | License | Publisher/Copright statement | Content | |
|---|---|---|---|---|---|---|---|
| EMBO_Reports_-_2022_-_Callegari_-_Potent_neutralization_by_monoclonal_human_IgM_against_SARS_CoV_2_is_impaired_by_class.pdf | text | Adobe PDF | 1.28 MB | published |